Sulphonylurea usage in melioidosis is associated with severe disease and suppressed immune response

Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the the Gram negative saprophytic bacillus Burkholderia pseudomallei is endemic with the risk of fulminant septicaemia. While diabetes mellitus is a well-established risk factor for melioidiosi...

Full description

Saved in:
Bibliographic Details
Published inPLoS neglected tropical diseases Vol. 8; no. 4; p. e2795
Main Authors Liu, Xiang, Foo, Geraldine, Lim, Wan Peng, Ravikumar, Sharada, Sim, Siew Hoon, Win, Mar Soe, Goh, Jessamine Geraldine, Lim, Joan Hui Juan, Ng, Ying Hui, Fisher, Dale, Khoo, Chin Meng, Tan, Gladys, Chai, Louis Yi Ann
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.04.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the the Gram negative saprophytic bacillus Burkholderia pseudomallei is endemic with the risk of fulminant septicaemia. While diabetes mellitus is a well-established risk factor for melioidiosis, little is known if specific hypoglycemic agents may differentially influence the susceptibility and clinical course of infection with B. pseudomallei (Bp). In this cohort study, patients with pre-existing diabetes and melioidosis were retrospectively studied. mortality, length of stay and development of complications (namely hypotension, intubation, renal failure and septicaemia) were studied in relation to prior diabetic treatment regimen. Peripheral blood mononuclear cells (PBMC) from diabetic patients and healthy PBMC primed with metformin, glyburide and insulin were stimulated with purified Bp antigens in vitro. Immune response and specific immune pathway mediators were studied to relate to the clinical findings mechanistically. Of 74 subjects, 44 (57.9%) had sulphonylurea-containing diabetic regimens. Patient receiving sulphonylureas had more severe septic complications (47.7% versus 16.7% p = 0.006), in particular, hypotension requiring intropes (p = 0.005). There was also a trend towards increased mortality in sulphonylurea-users (15.9% versus 3.3% p = 0.08). In-vitro, glyburide suppressed inflammatory cytokine production in a dose-dependent manner. An effect of the drug was the induction of IL-1R-associated kinase-M at the level of mRNA transcription. Sulphonylurea treatment results in suppression of host inflammatory response and may put patients at higher risk for adverse outcomes in melioidosis.
AbstractList Background: Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the the Gram negative saprophytic bacillus Burkholderia pseudomallei is endemic with the risk of fulminant septicaemia. While diabetes mellitus is a well-established risk factor for melioidiosis, little is known if specific hypoglycemic agents may differentially influence the susceptibility and clinical course of infection with B. pseudomallei (Bp). Methodology/Principal Findings: In this cohort study, patients with pre-existing diabetes and melioidosis were retrospectively studied. Outcome measures: mortality, length of stay and development of complications (namely hypotension, intubation, renal failure and septicaemia) were studied in relation to prior diabetic treatment regimen. Peripheral blood mononuclear cells (PBMC) from diabetic patients and healthy PBMC primed with metformin, glyburide and insulin were stimulated with purified Bp antigens in vitro. Immune response and specific immune pathway mediators were studied to relate to the clinical findings mechanistically. Of 74 subjects, 44 (57.9%) had sulphonylurea-containing diabetic regimens. Patient receiving sulphonylureas had more severe septic complications (47.7% versus 16.7% p = 0.006), in particular, hypotension requiring intropes (p = 0.005). There was also a trend towards increased mortality in sulphonylurea-users (15.9% versus 3.3% p = 0.08). In-vitro, glyburide suppressed inflammatory cytokine production in a dose-dependent manner. An effect of the drug was the induction of IL-1R- associated kinase-M at the level of mRNA transcription. Conclusion/Significance: Sulphonylurea treatment results in suppression of host inflammatory response and may put patients at higher risk for adverse outcomes in melioidosis.
Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the Gram negative bacillus Burkholderia pseudomallei can cause life-threatening infection. Diabetes mellitus is a recognised risk factor for melioidiosis; however little is known if commonly used anti-diabetic drugs may affect the clinical course of the disease. In this study, we found that patients who were receiving sulphonylureas for diabetic treatment had more severe septic complications requiring intensive care as well as increased risk of deaths. This may be attributable to the capacity of sulphonylureas in modulating the host immune response. We highlight caution in the prescription of this class of drug, which is popular due to its low cost and easy availability, especially in melioidosis-endemic tropical regions.
Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the the Gram negative saprophytic bacillus Burkholderia pseudomallei is endemic with the risk of fulminant septicaemia. While diabetes mellitus is a well-established risk factor for melioidiosis, little is known if specific hypoglycemic agents may differentially influence the susceptibility and clinical course of infection with B. pseudomallei (Bp). In this cohort study, patients with pre-existing diabetes and melioidosis were retrospectively studied. mortality, length of stay and development of complications (namely hypotension, intubation, renal failure and septicaemia) were studied in relation to prior diabetic treatment regimen. Peripheral blood mononuclear cells (PBMC) from diabetic patients and healthy PBMC primed with metformin, glyburide and insulin were stimulated with purified Bp antigens in vitro. Immune response and specific immune pathway mediators were studied to relate to the clinical findings mechanistically. Of 74 subjects, 44 (57.9%) had sulphonylurea-containing diabetic regimens. Patient receiving sulphonylureas had more severe septic complications (47.7% versus 16.7% p = 0.006), in particular, hypotension requiring intropes (p = 0.005). There was also a trend towards increased mortality in sulphonylurea-users (15.9% versus 3.3% p = 0.08). In-vitro, glyburide suppressed inflammatory cytokine production in a dose-dependent manner. An effect of the drug was the induction of IL-1R-associated kinase-M at the level of mRNA transcription. Sulphonylurea treatment results in suppression of host inflammatory response and may put patients at higher risk for adverse outcomes in melioidosis.
Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the Gram negative bacillus Burkholderia pseudomallei can cause life-threatening infection. Diabetes mellitus is a recognised risk factor for melioidiosis; however little is known if commonly used anti-diabetic drugs may affect the clinical course of the disease. In this study, we found that patients who were receiving sulphonylureas for diabetic treatment had more severe septic complications requiring intensive care as well as increased risk of deaths. This may be attributable to the capacity of sulphonylureas in modulating the host immune response. We highlight caution in the prescription of this class of drug, which is popular due to its low cost and easy availability, especially in melioidosis-endemic tropical regions.
  Background Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the the Gram negative saprophytic bacillus Burkholderia pseudomallei is endemic with the risk of fulminant septicaemia. While diabetes mellitus is a well-established risk factor for melioidiosis, little is known if specific hypoglycemic agents may differentially influence the susceptibility and clinical course of infection with B. pseudomallei (Bp). Methodology/Principal Findings In this cohort study, patients with pre-existing diabetes and melioidosis were retrospectively studied. Outcome measures: mortality, length of stay and development of complications (namely hypotension, intubation, renal failure and septicaemia) were studied in relation to prior diabetic treatment regimen. Peripheral blood mononuclear cells (PBMC) from diabetic patients and healthy PBMC primed with metformin, glyburide and insulin were stimulated with purified Bp antigens in vitro. Immune response and specific immune pathway mediators were studied to relate to the clinical findings mechanistically. Of 74 subjects, 44 (57.9%) had sulphonylurea-containing diabetic regimens. Patient receiving sulphonylureas had more severe septic complications (47.7% versus 16.7% p = 0.006), in particular, hypotension requiring intropes (p = 0.005). There was also a trend towards increased mortality in sulphonylurea-users (15.9% versus 3.3% p = 0.08). In-vitro, glyburide suppressed inflammatory cytokine production in a dose-dependent manner. An effect of the drug was the induction of IL-1R-associated kinase-M at the level of mRNA transcription. Conclusion/Significance Sulphonylurea treatment results in suppression of host inflammatory response and may put patients at higher risk for adverse outcomes in melioidosis.
Audience Academic
Author Liu, Xiang
Win, Mar Soe
Ng, Ying Hui
Ravikumar, Sharada
Sim, Siew Hoon
Fisher, Dale
Khoo, Chin Meng
Foo, Geraldine
Lim, Joan Hui Juan
Chai, Louis Yi Ann
Goh, Jessamine Geraldine
Lim, Wan Peng
Tan, Gladys
AuthorAffiliation University of California San Diego School of Medicine, United States of America
3 Department of Pharmacy, Tan Tock Seng Hospital, Singapore
1 Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore
2 Department of Pharmacy, National University Hospital, Singapore
6 Division of Endocrinology, University Medicine Cluster, National University Health System, Singapore
5 Faculty of Medicine, National University of Singapore, Singapore
4 Defence Medical and Environmental Research Institute, DSO National Laboratories, Singapore
AuthorAffiliation_xml – name: 3 Department of Pharmacy, Tan Tock Seng Hospital, Singapore
– name: 6 Division of Endocrinology, University Medicine Cluster, National University Health System, Singapore
– name: 5 Faculty of Medicine, National University of Singapore, Singapore
– name: University of California San Diego School of Medicine, United States of America
– name: 2 Department of Pharmacy, National University Hospital, Singapore
– name: 1 Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore
– name: 4 Defence Medical and Environmental Research Institute, DSO National Laboratories, Singapore
Author_xml – sequence: 1
  givenname: Xiang
  surname: Liu
  fullname: Liu, Xiang
  organization: Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore
– sequence: 2
  givenname: Geraldine
  surname: Foo
  fullname: Foo, Geraldine
  organization: Department of Pharmacy, National University Hospital, Singapore
– sequence: 3
  givenname: Wan Peng
  surname: Lim
  fullname: Lim, Wan Peng
  organization: Department of Pharmacy, Tan Tock Seng Hospital, Singapore
– sequence: 4
  givenname: Sharada
  surname: Ravikumar
  fullname: Ravikumar, Sharada
  organization: Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore
– sequence: 5
  givenname: Siew Hoon
  surname: Sim
  fullname: Sim, Siew Hoon
  organization: Defence Medical and Environmental Research Institute, DSO National Laboratories, Singapore
– sequence: 6
  givenname: Mar Soe
  surname: Win
  fullname: Win, Mar Soe
  organization: Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore
– sequence: 7
  givenname: Jessamine Geraldine
  surname: Goh
  fullname: Goh, Jessamine Geraldine
  organization: Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore
– sequence: 8
  givenname: Joan Hui Juan
  surname: Lim
  fullname: Lim, Joan Hui Juan
  organization: Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore
– sequence: 9
  givenname: Ying Hui
  surname: Ng
  fullname: Ng, Ying Hui
  organization: Department of Pharmacy, National University Hospital, Singapore
– sequence: 10
  givenname: Dale
  surname: Fisher
  fullname: Fisher, Dale
  organization: Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore; Faculty of Medicine, National University of Singapore, Singapore
– sequence: 11
  givenname: Chin Meng
  surname: Khoo
  fullname: Khoo, Chin Meng
  organization: Faculty of Medicine, National University of Singapore, Singapore; Division of Endocrinology, University Medicine Cluster, National University Health System, Singapore
– sequence: 12
  givenname: Gladys
  surname: Tan
  fullname: Tan, Gladys
  organization: Defence Medical and Environmental Research Institute, DSO National Laboratories, Singapore
– sequence: 13
  givenname: Louis Yi Ann
  surname: Chai
  fullname: Chai, Louis Yi Ann
  organization: Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24762472$$D View this record in MEDLINE/PubMed
BookMark eNptkl1rHCEUhqWkNMm2_6C0A4XSm936MTp6UwihH4FAL9pei6tndg2OTnUmJf--bncTdqGo-PWcVz2-l-gspggIvSZ4RVhHPt6lOUcTVmOc3ApjTDvFn6ELohhf0o7xs6PxObos5Q5jrrgkL9A5bTtRG71A9sccxm2KD2HOYJq5mA00PjYDBJ-8S8WXplZTSrLeTOCaP37aNgXuIUPjfAFToDHRNWUexwylVMQPwxyhqbMxxQIv0fPehAKvDv0C_fry-ef1t-Xt968311e3SyuompZizZWknWQgGCfMciDOdgo60Tsh7boXbs3B9o6KjrXM4VY5zh04ZlupWsoW6O1edwyp6EN-iiacciolb0UlbvaES-ZOj9kPJj_oZLz-t5DyRps8eRtACwnGSOEIhXVLeip5hwlWrjeu4xi7qvXpcNq8HsBZiFM24UT0dCf6rd6ke82Ukqr-ygJ9OAjk9HuGMunBFwshmAhp3t2btZJIwWRF3-3RjalX87FPVdHucH3FhMKiZWT3_tV_qFocDN5W9_S-rp8EvD8K2IIJ07akME--ftsp2O5Bm1MpGfqnZxKsd258zLbeuVEf3FjD3hyn6Cno0X7sL2jz4AI
CitedBy_id crossref_primary_10_1128_mBio_01932_17
crossref_primary_10_1080_14787210_2018_1496330
crossref_primary_10_3390_ijms23094641
crossref_primary_10_3390_tropicalmed3010031
crossref_primary_10_1136_bcr_2020_238200
crossref_primary_10_1038_nrdp_2017_107
crossref_primary_10_1016_j_smim_2014_10_001
crossref_primary_10_1371_journal_pntd_0007380
crossref_primary_10_1016_S2213_8587_16_30081_X
crossref_primary_10_1007_s40265_016_0674_0
Cites_doi 10.1097/CCM.0b013e318194b1bf
10.1097/CCM.0b013e31827e83af
10.1097/QCO.0b013e32833fb88c
10.1128/CMR.00001-11
10.1086/318116
10.1093/cid/ciq192
10.1128/IAI.01455-08
10.1172/JCI57817
10.1056/NEJMra1204699
10.3201/eid0912.020750
10.1097/QCO.0b013e328322e727
10.1124/jpet.109.164970
10.4081/idr.2010.e9
10.1016/S0035-9203(08)70002-6
10.1083/jcb.200903124
ContentType Journal Article
Copyright COPYRIGHT 2014 Public Library of Science
2014 Liu et al 2014 Liu et al
2014 Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Liu X, Foo G, Lim WP, Ravikumar S, Sim SH, et al. (2014) Sulphonylurea Usage in Melioidosis Is Associated with Severe Disease and Suppressed Immune Response. PLoS Negl Trop Dis 8(4): e2795. doi:10.1371/journal.pntd.0002795
Copyright_xml – notice: COPYRIGHT 2014 Public Library of Science
– notice: 2014 Liu et al 2014 Liu et al
– notice: 2014 Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Liu X, Foo G, Lim WP, Ravikumar S, Sim SH, et al. (2014) Sulphonylurea Usage in Melioidosis Is Associated with Severe Disease and Suppressed Immune Response. PLoS Negl Trop Dis 8(4): e2795. doi:10.1371/journal.pntd.0002795
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7T5
C1K
H94
5PM
DOA
DOI 10.1371/journal.pntd.0002795
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
DatabaseTitleList



MEDLINE
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Sulphonylurea and Severe Disease in Melioidosis
EISSN 1935-2735
Editor Vinetz, Joseph M.
Editor_xml – sequence: 1
  givenname: Joseph M.
  surname: Vinetz
  fullname: Vinetz, Joseph M.
ExternalDocumentID 1525288546
oai_doaj_org_article_68eaa86d12eb41f28570109dfad7500d
A369064312
10_1371_journal_pntd_0002795
24762472
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Asia, Southeastern
Australia
GeographicLocations_xml – name: Asia, Southeastern
– name: Australia
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7X7
88E
8C1
8FI
8FJ
AAFWJ
ABDBF
ABUWG
ACGFO
ACIHN
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
BWKFM
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAP
EAS
EBD
ECGQY
ECM
EIF
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
IHW
IPNFZ
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PV9
RIG
RNS
RPM
RZL
SV3
TR2
TUS
UKHRP
WOQ
AAYXX
CITATION
AFPKN
7QL
7T5
C1K
H94
5PM
-
AAPBV
ABPTK
ADACO
BBAFP
PQEST
PQUKI
PRINS
ID FETCH-LOGICAL-c629t-6b5982783e63513c5e1dc79e76fd68cbf6db5ecfd267343d049d55ded3c489423
IEDL.DBID RPM
ISSN 1935-2735
1935-2727
IngestDate Fri Nov 26 17:13:54 EST 2021
Tue Oct 22 15:13:05 EDT 2024
Tue Sep 17 21:21:01 EDT 2024
Thu Oct 24 22:50:28 EDT 2024
Tue Nov 19 20:20:17 EST 2024
Tue Nov 12 22:55:07 EST 2024
Tue Aug 20 22:09:35 EDT 2024
Fri Nov 22 01:00:41 EST 2024
Tue Oct 15 23:49:22 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Length of Stay
Diabetes Complications
Humans
Middle Aged
Male
Treatment Outcome
Diabetes Mellitus
Asia, Southeastern
Melioidosis
Hypoglycemic Agents
Survival Analysis
Female
Sepsis
Retrospective Studies
Sulfonylurea Compounds
Australia
Cohort Studies
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c629t-6b5982783e63513c5e1dc79e76fd68cbf6db5ecfd267343d049d55ded3c489423
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Conceived and designed the experiments: XL WPL YHN DF CMK GT LYAC. Performed the experiments: XL GF WPL SR SHS MSW JGG JHJL. Analyzed the data: XL GF WPL SR SHS MSW CMK GT LYAC. Contributed reagents/materials/analysis tools: SHS GT. Wrote the paper: XL SR DF GT CMK LYAC.
The authors have declared that no competing interests exist.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998927/
PMID 24762472
PQID 1534818638
PQPubID 23462
ParticipantIDs plos_journals_1525288546
doaj_primary_oai_doaj_org_article_68eaa86d12eb41f28570109dfad7500d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3998927
proquest_miscellaneous_1534818638
gale_infotracmisc_A369064312
gale_infotracacademiconefile_A369064312
gale_healthsolutions_A369064312
crossref_primary_10_1371_journal_pntd_0002795
pubmed_primary_24762472
PublicationCentury 2000
PublicationDate 2014-04-01
PublicationDateYYYYMMDD 2014-04-01
PublicationDate_xml – month: 04
  year: 2014
  text: 2014-04-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco, USA
PublicationTitle PLoS neglected tropical diseases
PublicationTitleAlternate PLoS Negl Trop Dis
PublicationYear 2014
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References 19114913 - Crit Care Med. 2009 Feb;37(2):569-76
21293047 - Clin Infect Dis. 2011 Mar 15;52(6):717-25
19204090 - Infect Immun. 2009 May;77(5):2184-92
11049780 - Clin Infect Dis. 2000 Oct;31(4):981-6
19276877 - Curr Opin Infect Dis. 2009 Apr;22(2):102-8
23353941 - Crit Care Med. 2013 Feb;41(2):580-637
20371705 - J Pharmacol Exp Ther. 2010 Jul;334(1):206-13
14720392 - Emerg Infect Dis. 2003 Dec;9(12):1538-42
21734245 - Clin Microbiol Rev. 2011 Jul;24(3):490-7
20847695 - Curr Opin Infect Dis. 2010 Dec;23(6):554-9
19121666 - Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S1-4
22546856 - J Clin Invest. 2012 Jun;122(6):2289-300
22256484 - J Med Assoc Thai. 2011 Nov;94(11):1410-7
22970946 - N Engl J Med. 2012 Sep 13;367(11):1035-44
21390243 - Infect Dis Rep. 2010 Jan 1;2(1):null
19805629 - J Cell Biol. 2009 Oct 5;187(1):61-70
M Arai (ref6) 2010; 334
GC Koh (ref10) 2011; 52
WJ Wiersinga (ref16) 2012; 367
P Panomket (ref8) 2011; 94
BJ Currie (ref3) 2008; 102 Suppl 1
LY Chai (ref13) 2009; 77
LL Hubbard (ref14) 2010; 2
WJ Wiersinga (ref9) 2009; 37
RP Dellinger (ref12) 2012; 41
AC Cheng (ref11) 2009; 23
C Picard (ref15) 2011; 24
WJ Wiersinga (ref7) 2009; 22
BJ Currie (ref1) 2003; 9
BJ Currie (ref2) 2000; 31
KS Tan (ref4) 2012; 122
M Lamkanfi (ref5) 2009; 187
References_xml – volume: 37
  start-page: 569
  year: 2009
  ident: ref9
  article-title: Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis)
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0b013e318194b1bf
  contributor:
    fullname: WJ Wiersinga
– volume: 94
  start-page: 1410
  year: 2011
  ident: ref8
  article-title: Immune response to Burkholderia pseudomallei
  publication-title: J Med Assoc Thai
  contributor:
    fullname: P Panomket
– volume: 41
  start-page: 580
  year: 2012
  ident: ref12
  article-title: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0b013e31827e83af
  contributor:
    fullname: RP Dellinger
– volume: 23
  start-page: 554
  year: 2009
  ident: ref11
  article-title: Melioidosis: advances in diagnosis and treatment
  publication-title: Curr Opin Infect Dis
  doi: 10.1097/QCO.0b013e32833fb88c
  contributor:
    fullname: AC Cheng
– volume: 24
  start-page: 490
  year: 2011
  ident: ref15
  article-title: Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00001-11
  contributor:
    fullname: C Picard
– volume: 31
  start-page: 981
  year: 2000
  ident: ref2
  article-title: Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature
  publication-title: Clin Infect Dis
  doi: 10.1086/318116
  contributor:
    fullname: BJ Currie
– volume: 52
  start-page: 717
  year: 2011
  ident: ref10
  article-title: Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciq192
  contributor:
    fullname: GC Koh
– volume: 77
  start-page: 2184
  year: 2009
  ident: ref13
  article-title: Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus
  publication-title: Infect Immun
  doi: 10.1128/IAI.01455-08
  contributor:
    fullname: LY Chai
– volume: 122
  start-page: 2289
  year: 2012
  ident: ref4
  article-title: Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria
  publication-title: J Clin Invest
  doi: 10.1172/JCI57817
  contributor:
    fullname: KS Tan
– volume: 367
  start-page: 1035
  year: 2012
  ident: ref16
  article-title: Melioidosis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1204699
  contributor:
    fullname: WJ Wiersinga
– volume: 9
  start-page: 1538
  year: 2003
  ident: ref1
  article-title: Intensity of rainfall and severity of melioidosis, Australia
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid0912.020750
  contributor:
    fullname: BJ Currie
– volume: 22
  start-page: 102
  year: 2009
  ident: ref7
  article-title: Immunity to Burkholderia pseudomallei
  publication-title: Curr Opin Infect Dis
  doi: 10.1097/QCO.0b013e328322e727
  contributor:
    fullname: WJ Wiersinga
– volume: 334
  start-page: 206
  year: 2010
  ident: ref6
  article-title: Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.109.164970
  contributor:
    fullname: M Arai
– volume: 2
  start-page: 1
  year: 2010
  ident: ref14
  article-title: IRAK-M regulation and function in host defense and immune homeostasis
  publication-title: Infect Dis Rep
  doi: 10.4081/idr.2010.e9
  contributor:
    fullname: LL Hubbard
– volume: 102 Suppl 1
  start-page: S1
  year: 2008
  ident: ref3
  article-title: The global distribution of Burkholderia pseudomallei and melioidosis: an update
  publication-title: Trans R Soc Trop Med Hyg
  doi: 10.1016/S0035-9203(08)70002-6
  contributor:
    fullname: BJ Currie
– volume: 187
  start-page: 61
  year: 2009
  ident: ref5
  article-title: Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200903124
  contributor:
    fullname: M Lamkanfi
SSID ssj0059581
Score 2.1656935
Snippet Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the the Gram negative saprophytic bacillus...
Background: Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the the Gram negative saprophytic...
Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the Gram negative bacillus Burkholderia pseudomallei...
Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the Gram negative bacillus Burkholderia pseudomallei...
BACKGROUND: Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the the Gram negative saprophytic...
  Background Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the the Gram negative saprophytic...
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e2795
SubjectTerms Asia, Southeastern
Australia
Bacillus
Biology and Life Sciences
Burkholderia pseudomallei
Care and treatment
Cohort Studies
Diabetes
Diabetes Complications - epidemiology
Diabetes Mellitus - drug therapy
Disease susceptibility
Female
Health aspects
Hospitals
Humans
Hypoglycemic Agents - adverse effects
Hypoglycemic Agents - therapeutic use
Immune response
Infections
Length of Stay
Male
Medicine and Health Sciences
Melioidosis - complications
Melioidosis - immunology
Melioidosis - mortality
Melioidosis - pathology
Middle Aged
Mortality
Pseudomonas infections
Retrospective Studies
Risk factors
Sepsis - mortality
Sepsis - pathology
Studies
Sulfonylurea Compounds - adverse effects
Sulfonylurea Compounds - therapeutic use
Surface water
Survival Analysis
Treatment Outcome
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA-yD-KL-H09T40g-NS7Nmk--niKxyGcL3pwb6VNJlg422W7-_87k2aXrQi-CPu0nV3IzGTml2bmN4x9cJhySuVMHtt68LxR511hqxwjn5QQMIFFkqSbb_r6tvp6p-6ORn1RTdhMDzwr7kJbaFurfSmgq8ogiJC9LGofWo_JrvAx-hZif5iaY7CqVRxPiuiEOq6ESU1z0pQXyUbn62Hrz-PNG82WOEpKkbv_EKFX6_tx-hv8_LOK8igtXT1hjxOe5JfzOp6yBzA8Yw9v0o35c-a-H5ef8x3VkfF-4L_gvh97P079xPHTJiuB5_RmlmO-hA3wdH3D28HzabeORbMo0lNTCfDNXF8LL9jt1Zcfn6_zNFghd1rU21x3RNtnrASEG6V0CkrvTA1GB6-t64L2nQIXvNBGVtLjKcIr5cFLV9kaAdhLthrGAU4YVxp0Haz0LWKxosPDm9Sl0xBKBUG2IWP5XrPNeubPaOIlmsFzx6yihizRJEtk7BOp_yBL7NfxC_SJJvlE8y-fyNg7Ml4zt5Ie9nBzKYmWGSGTyNjHKEG7GI3n2tSMgIsiPqyF5NlCEnefWzw-IQfZr2VqaJ6UsFZVOmPv907T0K-omm2AcUcy1P5sMfRl7NXsRIcFiwrTU2Xwj83CvRYaWT4Z-p-RFxyxpq2FOf0fKnzNHiE0TDVKZ2y13ezgDcKvbfc27rTffC8s7A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEF_qCeKL-N3UqisIPuW4ZLMfeRCpYinC-aIHfQvJ7kQD1-RM7qD-985s9o5GKgh5SiaB3ZnZ-U3mi7G3Fk1OIq2OfVkP-ht5XC1MFuPJJwTUaMB8k6TlV3Wxyr5cyssjtp_ZGjZwuNW1o3lSq349v_71-wMq_Hs_tUEn-5fmm3br5j6Wlss77G6KtpGSvJbZIa4gc-nHliJqoUqsVIdiun99ZWKsfE__w8k926y74TZY-nd25Q1zdf6QPQg4k5-NgvGIHUH7mN1bhkj6E2a_3UxL5zvKL-NNy69g3XSN64Zm4HiVgXvgOP2x5WhHoQcewjq8bB0fdhufTIskDRWbAO_HvFt4ylbnn79_uojDwIXYqjTfxqqidn7aCEAYkggrIXFW56BV7ZSxVa1cJcHWLlVaZMKhd-GkdOCEzUyOwOwZm7VdC8eMSwUqr41wJWK0RYVOnVCJVVAnEmpR1hGL9ztbbMa-GoUPrmn0R8YtKogTReBExD7S9h9oqSu2v9H1P4qgZIUyUJZGuSSFKkvqlJr3J4vc1aVDYLRwEXtNzCvGEtODbhdngto1o7ikEXvnKUjekHm2DEUKuCjqkzWhPJ1QolbayeNjEpD9WoaC5kylxshMRezNXmgKeouy3FrodkRDZdEGj8SIPR-F6LDgNEOzlWn8sJ6I12RHpk_a5qfvF44Y1OSpPvnvtb1g9xEXhgSlUzbb9jt4idhrW73y6vQHiS8uXA
  priority: 102
  providerName: Scholars Portal
Title Sulphonylurea usage in melioidosis is associated with severe disease and suppressed immune response
URI https://www.ncbi.nlm.nih.gov/pubmed/24762472
https://search.proquest.com/docview/1534818638
https://pubmed.ncbi.nlm.nih.gov/PMC3998927
https://doaj.org/article/68eaa86d12eb41f28570109dfad7500d
http://dx.doi.org/10.1371/journal.pntd.0002795
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF4SF0ovpe-oTd0tFHqSbWm1Dx0TNyEpOISkBt-EtDtKBY5kYuf_d2Ylmaj01IsO0gi0O69vtPNg7JtFlxNJq0Nf1oPxRhoWM5OEaPmEgBIdmG-StLhSF8vk50quDpjsa2F80r4tqkm9vp_U1W-fW7m5t9M-T2x6vZijUzUpxuyH7BDdbx-it-ZXptJPJkVgQsVWse7q5YSOph17Jpt65yb-0C2lyTVxghYh0fHANfkO_ns7Pdqsm-2_QOjfuZRPnNP5K_ayQ5X8pP361-wA6jfs-aI7N3_L7O3TJHS-pGwyXtV8AeuqqVyzrbb8cst7XoHj9H-W3wIKOvAf7SEOz2vHaQqo7zfu-CWVlgC_abNs4R1bnp_9ml-E3XiF0Ko43YWqoOZ92ghA0BEJKyFyVqegVemUsUWpXCHBli5WWiTCYSzhpHTghE1MijDsPRvVTQ1HjEsFKi2NcDkislmB7BEqsgrKSEIp8jJgYb-z2abtopH5ozSN0Ue7RRkxJeuYErBT2v49LfXA9jeah7usk4RMGchzo1wUQ5FEZUyt-qNZ6srcIQyauYB9IeZlbUHpXpOzE0HNmRE4xQH77ilIl5F5Nu9KEnBR1BVrQHk8oEQdtIPHRyQg_Vq2GU2Vio2RiQrY115oMnqLctpqaB6JhoqgDRrAgH1ohWi_4F4kA6YH4jXYkeETVBbfHbxTjo___eYn9gJRYZeedMxGu4dH-IzIa1eMUd9WGq9mHo3Zs9Ozq-ubsf-LgddFYsZeE_8AGY8xfQ
link.rule.ids 230,314,727,780,784,864,885,2102,2221,24318,27924,27925,31720,33267,33745,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGkYCXic8tMJiRkHhK28TxRx7HYGphmRBbpb1ZiX2BSF1SLd3_v7OTVAviidfGkWLf1-_qu98R8slgyIm4kaFv68F8Iw2LuUpC9HyMQYkBzJMkZRdisUq-X_PrPcKHXhhftG-Kalqvb6Z19cfXVm5uzGyoE5v9zE4xqKoUc_ZH5DFnMo2GJL1zwDzlfjYpQhPXbhXLvmOOyWjWC2i6qbd26q_dUje7Jk7QJyQyHgUnz-G_89STzbpp_wVD_66mfBCezp6T_R5X0pPu-1-QPahfkidZf3P-ipjLh2XodOXqyWhV0wzWVVPZpq1aumzpIC2w1P1DSy8BVR3o1-4ah-a1pW4OqGcct3TpmkuA_urqbOE1WZ19uzpdhP2AhdCION2GonD0fVIxQNgRMcMhskamIEVphTJFKWzBwZQ2FpIlzGI2YTm3YJlJVIpA7A2Z1E0Nh4RyASItFbM5YrJ5gQJiIjICyohDyfIyIOFwsnrT8Whof5kmMf_ojkg7oeheKAH54o5_t9axYPsfmtvfutcFLRTkuRI2iqFIojJ2ZP3RPLVlbhEIzW1Ajp3wdNdSurNlfcIcPTNCpzggn_0KZ80oPJP3TQm4KceLNVp5NFqJVmhGjw-dggx7abWbKxUrxRMRkI-D0mj3lqtqq6G5c2tcG7RCFxiQg06JdhseVDIgcqReoxMZP0Fz8fzgvXm8_e83j8nTxVV2rs-XFz_ekWeIEftipSMy2d7ewXvEYdvig7e6eyhDL7U
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZgkSouiHdDCzUSEqfsbuLYcY6lZdUFtqooK_VmJX5ApG0SNdv_3xknWW0QJ66Jc7Dn9U088w0hnzSEnIjrNPRtPZBvZGExl0kIno8x6yCAeZKk1aW4WCffbvjN3qgvX7Svi3JabW6nVfnH11Y2t3o21InNrlZnEFRlBjl7Y9zsMXnCGSjZkKh3Tphn3M8nBXiCLVdx2nfNsTSa9UKaNtXWTP3VW4bza-IE_EKSxqMA5Xn8d9560mzq9l9Q9O-Kyr0QtXhOnvXYkp52e3hBHtnqJTlY9bfnr4i-3i9Fp2usKaNlRVd2U9alqduypcuWDhKzhuJfWnptQd0tPe-ucmheGYqzQD3ruKFLbDCx9GdXa2tfk_Xi66-zi7AfshBqEWfbUBRI4ZdKZgF6RExzGxmdZjYVzgipCydMwa12JhYpS5iBjMJwbqxhOpEZgLE3ZFLVlT0klAsrMieZyQGXzQsQEhORFtZF3DqWu4CEw8mqpuPSUP5CLYUcpDsihUJRvVAC8gWPf7cWmbD9g_rut-r1QQlp81wKE8W2SCIXI2F_NM-Myw2AobkJyAkKT3VtpTt7VqcMKZoBPsUB-exXoEWD8HTeNybAppAba7TyeLQSLFGPXh-iggx7aRXOloql5IkIyMdBaRR-hZVtla3vcQ22QktwgwF52ynRbsODSgYkHanX6ETGb8BkPEd4byLv_vvLE3Jwdb5QP5aX34_IU4CJfb3SMZls7-7te4Bi2-KDN7oHdtcwyA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sulphonylurea+usage+in+melioidosis+is+associated+with+severe+disease+and+suppressed+immune+response&rft.jtitle=PLoS+neglected+tropical+diseases&rft.au=Liu%2C+Xiang&rft.au=Foo%2C+Geraldine&rft.au=Lim%2C+Wan+Peng&rft.au=Ravikumar%2C+Sharada&rft.date=2014-04-01&rft.pub=Public+Library+of+Science&rft.issn=1935-2727&rft.volume=8&rft.issue=4&rft_id=info:doi/10.1371%2Fjournal.pntd.0002795&rft.externalDocID=A369064312
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1935-2735&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1935-2735&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1935-2735&client=summon